Noronha R F, Goodall C M
Carcinogenesis. 1983;4(5):613-6. doi: 10.1093/carcin/4.5.613.
The effect of androgenic treatments on single dose dimethylnitrosamine (DMN) carcinogenesis was studied in 60 female NZR/Gd inbred rats, 25 of which were intact and received DMN 20 mg/kg i.p. in one dose after 48 h starvation, while 35 received DMN combined with testosterone injections every 4 weeks beginning 15 days before or after DMN, and in 29 rats combined also with ovariectomy. Sixteen female rats underwent ovariectomy and received testosterone every 4 weeks with no DMN. There were also 107 untreated intact contemporaneous control female rats. A single dose of DMN induced alveologenic lung (16%), hepatocellular (24%) and kidney epithelial (44%) tumours in intact rats, and the incidences of lethal tumours at these sites were significantly enhanced by androgenic treatments following the carcinogen, most markedly in the kidney. Androgenic treatment given before DMN injection had no significant effect on kidney or liver tumour incidences, but the carcinogenic response in lung was still strongly enhanced.
在60只雌性NZR/Gd近交系大鼠中研究了雄激素治疗对单剂量二甲基亚硝胺(DMN)致癌作用的影响。其中25只未处理的大鼠在禁食48小时后腹腔注射20mg/kg的DMN;35只大鼠在DMN注射前或注射后15天开始,每4周注射睾酮并联合DMN,其中29只大鼠还进行了卵巢切除术。16只雌性大鼠进行了卵巢切除术,每4周接受睾酮注射,但未注射DMN。另外还有107只未处理的同期对照雌性大鼠。单剂量的DMN在未处理的大鼠中诱发了肺泡源性肺癌(16%)、肝细胞癌(24%)和肾上皮癌(44%),致癌物注射后进行雄激素治疗显著增加了这些部位的致死性肿瘤发生率,在肾脏中最为明显。在DMN注射前进行雄激素治疗对肾脏或肝脏肿瘤发生率没有显著影响,但对肺部的致癌反应仍有强烈增强作用。